Zobrazeno 1 - 1
of 1
pro vyhledávání: '"S S, Tanciongco"'
Autor:
D B, Mendel, R E, Schreck, D C, West, G, Li, L M, Strawn, S S, Tanciongco, S, Vasile, L K, Shawver, J M, Cherrington
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 6(12)
SU5416, a selective inhibitor of the tyrosine kinase activity of the vascular endothelial growth factor (VEGF) receptor Flk-1/KDR, is currently in Phase III clinical trials for the treatment of advanced malignancies. In cellular assays, SU5416 inhibi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f858777337e62ff407dc874da23dd5be
https://pubmed.ncbi.nlm.nih.gov/11156244
https://pubmed.ncbi.nlm.nih.gov/11156244
